Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Fulcrum Therapeutics (FULC) shares
Learn how to easily invest in Fulcrum Therapeutics shares.
Fulcrum Therapeutics is a biotechnology business based in the US. Fulcrum Therapeutics stocks (FULC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.89 – a decrease of 10.97% over the previous week. Fulcrum Therapeutics employs 73 staff and has a trailing 12-month revenue of around $18.3 million.
How to buy shares in Fulcrum Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FULC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Fulcrum Therapeutics?
- Has coronavirus impacted Fulcrum Therapeutics shares?
- Fulcrum Therapeutics shares summary
- Compare share dealing platforms
- Is Fulcrum Therapeutics stock a buy or sell?
- Fulcrum Therapeutics performance over time
- Fulcrum Therapeutics's financials
- How volatile are Fulcrum Therapeutics shares?
- Does Fulcrum Therapeutics pay a dividend?
- Other common questions
Fulcrum Therapeutics stock price (NASDAQ:FULC)Use our graph to track the performance of FULC stocks over time.
Fulcrum Therapeutics shares at a glance
|Latest market close||$11.52|
|52-week range||$6.85 - $33.10|
|50-day moving average||$16.01|
|200-day moving average||$16.33|
|Wall St. target price||$35.43|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.34|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Fulcrum Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Fulcrum Therapeutics price performance over time
|1 week (2022-01-21)||-10.97%|
|1 month (2021-12-25)||N/A|
|3 months (2021-10-29)||-47.97%|
|6 months (2021-07-29)||54.01%|
|1 year (2021-01-29)||4.16%|
|2 years (2020-01-29)||-36.81%|
|3 years (2019-01-25)||N/A|
|5 years (2017-01-25)||N/A|
Fulcrum Therapeutics financials
|Revenue TTM||$18.3 million|
|Gross profit TTM||$-46,839,000|
|Return on assets TTM||-23.66%|
|Return on equity TTM||-44.75%|
|Market capitalisation||$524.7 million|
TTM: trailing 12 months
Fulcrum Therapeutics share dividends
We're not expecting Fulcrum Therapeutics to pay a dividend over the next 12 months.
Fulcrum Therapeutics share price volatility
Over the last 12 months, Fulcrum Therapeutics's shares have ranged in value from as little as $6.85 up to $33.098. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulcrum Therapeutics's is 1.3414. This would suggest that Fulcrum Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Fulcrum Therapeutics overview
Fulcrum Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that is in Phase 2b clinical trial for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-6058, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and ß-thalassemia. The company is also discovering drug targets for the treatments of muscle, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has research and discovery collaboration agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and has a strategic collaboration and license agreement with MyoKardia, Inc.
Fulcrum Therapeutics in the news
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
5 things to know before the stock market opens Thursday
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Bitcoin Private (BTCP) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.